Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID). 2006

Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
Laboratory of Neurogenetics, National Institute on Aging, Porter Neuroscience Building, Building 35 Room 1A1010 35 Convent Drive, Bethesda, MD 20892, USA. momeni@mail.nih.gov

Abnormal neuronal aggregates of alpha-internexin and the three neurofilament (NF) subunits, NFL, NFM, and NFH have recently been identified as the signature lesions of neuronal intermediate filament (IF) inclusion disease (NIFID), a novel neurological disease of early onset with a variable clinical phenotype including frontotemporal dementia, pyramidal and extrapyramidal signs. In other neurodegenerative diseases in which protein aggregates contribute to disease pathogenesis, mutations in the encoding protein cause the hereditary variant of the disease. To determine the molecular genetic contribution to this disease we performed a mutation analysis of all type IV neuronal IF, SOD1 and NUDEL genes in cases of NIFID and unaffected control cases. We found no pathogenic variants.

UI MeSH Term Description Entries
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002479 Inclusion Bodies A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed) Cellular Inclusions,Cytoplasmic Inclusions,Bodies, Inclusion,Body, Inclusion,Cellular Inclusion,Cytoplasmic Inclusion,Inclusion Body,Inclusion, Cellular,Inclusion, Cytoplasmic,Inclusions, Cellular,Inclusions, Cytoplasmic
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies

Related Publications

Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
November 2011, Journal of neural transmission (Vienna, Austria : 1996),
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
January 2008, Handbook of clinical neurology,
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
April 2005, Journal of neural transmission (Vienna, Austria : 1996),
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
January 2007, Journal of neural transmission (Vienna, Austria : 1996),
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
September 2004, Acta neuropathologica,
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
December 2011, Journal of neurology, neurosurgery, and psychiatry,
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
September 2006, Journal of neural transmission (Vienna, Austria : 1996),
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
January 2006, Clinical neuropathology,
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
May 2006, European journal of neurology,
Parastoo Momeni, and Nigel J Cairns, and Robert H Perry, and Eileen H Bigio, and Marla Gearing, and Andrew B Singleton, and John Hardy
February 2008, Archives of neurology,
Copied contents to your clipboard!